Health in Code offers the most complete genetic study for the assessment of patients with congenital heart diseases:
NGS Panel with 114 genes related to congenital heart diseases
Copy number variation analysis through SNP arrays
Whole-Exome Sequencing
Congenital heart diseases are the most frequent cause of congenital malformations in newborns, and are the first cause of infant death related to congenital malformations. Their prevalence is 8 to 14 out of every 1000 live births. Most congenital heart diseases have a multifactorial etiology. It is estimated that in 8%-10% of cases the cause is a chromosomal abnormality, and 3%-5% present within the context of a monogenic syndrome.
Specific molecular diagnosis for a genetic syndrome allows for appropriate advice and early medical follow-up. The American Heart Association (AHA) and the American Academy of Pediatrics have pointed out the main reasons to determine the genetic cause of congenital heart diseases: (1) identifying other organs and systems susceptible of medical follow-up; (2) obtaining specific information about the prognosis; (3) informing families about risks of recurrence; and (4) identifying relatives at risk and providing them with the necessary studies, including genetic study.
Individuals suspected or clinically diagnosed with a syndromic or non-syndromic (i.e. isolated) congenital heart disease. Upon familial history of congenital heart disease with a risk of recurrence, it is always necessary to try to determine its molecular etiology.
Familial study: relatives of patients with a syndromic or non-syndromic congenital heart disease in which a causal mutation has been previously identified.
It is recommended to rule out chromosomal abnormalities (karyotype, CGH-arrays, SNP arrays) in order to improve the yield of the test, especially when other malformations are present.
The NGS panel allows identifying mutations in some of the genes previously associated with the development of syndromic or non-syndromic congenital heart diseases.
Case analysis using whole-exome sequencing can be considered in cases where there is suspicion of a genetic cause for a congenital heart disease without an identified molecular cause, but the individual yield over our NGS panels is low.
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Turnaround time (TAT): 4 weeks
Ref. S-201601108
In case of isolated congenital heart disease.
In case of syndromic congenital heart disease related to genes included in the panel.
In case other causes for congenital heart disease (e.g. presence of chromosomal abnormalities) have been ruled out through another method, such as SNP arrays.
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
Panel that include congenital heart diseases genes
